ADAMAS Trademark

Trademark Overview

On Wednesday, August 28, 2013, a trademark application was filed for ADAMAS with the United States Patent and Trademark Office. The USPTO has given the ADAMAS trademark a serial number of 86050262. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, February 27, 2021. This trademark is owned by Adamas Pharmaceuticals, Inc.. The ADAMAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of nervous system disorders and conditions; pharmaceutical preparations for the prevention and treatment of Parkinson's disease
adamas

General Information

Serial Number86050262
Word MarkADAMAS
Filing DateWednesday, August 28, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, February 27, 2021
Registration Number4642260
Registration DateTuesday, November 18, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of nervous system disorders and conditions; pharmaceutical preparations for the prevention and treatment of Parkinson's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 6, 2013
Primary Code005
First Use Anywhere DateTuesday, July 15, 2014
First Use In Commerce DateTuesday, July 15, 2014

Trademark Owner History

Party NameAdamas Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameAdamas Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameAdamas Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Monday, March 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, November 18, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, February 27, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, February 27, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, February 22, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 17, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, November 18, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 18, 2014REGISTERED-PRINCIPAL REGISTER
Friday, October 17, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 16, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 29, 2014STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 16, 2014USE AMENDMENT FILED
Monday, September 29, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 16, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, March 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 12, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2013ASSIGNED TO EXAMINER
Friday, September 6, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 31, 2013NEW APPLICATION ENTERED

Related Keywords

adamas pharmaceutical prevention treatment preparations parkinson disease conditions nervous system disorders